Instadose Pharma Corp.
INSD - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$53.19K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $53,193.00 |
|---|---|
| Enterprise Value | $285,389.00 |
| Earnings per Share | $0 |
| Beta | 7.1 |
| Outstanding Shares | 531,934,000 |
Return
| Return on Equity | -4.83% |
|---|---|
| Return on Assets | -3.75% |
| Return on Invested Capital | -4.82% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.17 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.83 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Instadose Pharma Corp.
2 employees
CEO: Antonio Rocco Franchino
Founded in 2017 and based in Burlington, Canada, Instadose Pharma Corp. specializes in the international cultivation, processing, and distribution of pharmaceutical-grade cannabinoid oil.